Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hiebert, SW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 62 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hiebert, SW; Lutterbach, B; Amann, J
      Role of co-repressors in transcriptional repression mediated by the t(8;21), t(16;21), t(12;21), and inv(16) fusion proteins

      CURRENT OPINION IN HEMATOLOGY
    2. Nip, J; Strom, DK; Eischen, CM; Cleveland, JL; Zambetti, GP; Hiebert, SW
      E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation

      ONCOGENE
    3. Eischen, CM; Packham, G; Nip, J; Fee, BE; Hiebert, SW; Zambetti, GP; Cleveland, JL
      Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1

      ONCOGENE
    4. Wang, LL; Hiebert, SW
      TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3

      ONCOGENE
    5. Hiebert, SW; Lutterbach, B; Durst, K; Wang, LL; Linggi, B; Wu, S; Wood, L; Amann, J; King, D; Hou, Y
      Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    6. Amann, JM; Nip, J; Strom, DK; Lutterbach, B; Harada, H; Lenny, N; Downing, JR; Meyers, S; Hiebert, SW
      ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain

      MOLECULAR AND CELLULAR BIOLOGY
    7. Meyers, S; Hiebert, SW
      Alterations in subnuclear trafficking of nuclear regulatory factors in acute leukemia

      JOURNAL OF CELLULAR BIOCHEMISTRY
    8. Lutterbach, B; Hiebert, SW
      Role of the transcription factor AML-1 in acute leukemia and hematopoieticdifferentiation

      GENE
    9. Melnick, AM; Westendorf, JJ; Polinger, A; Carlile, GW; Arai, S; Ball, HJ; Lutterbach, B; Hiebert, SW; Licht, JD
      The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein

      MOLECULAR AND CELLULAR BIOLOGY
    10. Fenrick, R; Wang, LL; Nip, J; Amann, JM; Rooney, RJ; Walker-Daniels, J; Crawford, HC; Hulboy, DL; Kinch, MS; Matrisian, LM; Hiebert, SW
      TEL, a putative tumor suppressor, modulates cell growth and cell morphology of Ras-transformed cells while repressing the transcription of stromelysin-1

      MOLECULAR AND CELLULAR BIOLOGY
    11. Strom, DK; Nipp, J; Westendorf, JJ; Linggi, B; Lutterbach, B; Downing, JR; Lenny, N; Hiebert, SW
      Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle

      JOURNAL OF BIOLOGICAL CHEMISTRY
    12. Lutterbach, B; Westendorf, JJ; Linggi, B; Isaac, S; Seto, E; Hiebert, SW
      A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia

      JOURNAL OF BIOLOGICAL CHEMISTRY
    13. Melnick, A; Carlile, GW; McConnell, MJ; Polinger, A; Hiebert, SW; Licht, JD
      AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocptic leukemia zinc finger protein

      BLOOD
    14. Westendorf, JJ; Hiebert, SW
      Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia

      JOURNAL OF CELLULAR BIOCHEMISTRY
    15. Westendorf, JJ; Mernaugh, R; Hiebert, SW
      Identification and characterization of a protein containing formin homology (FH1/FH2) domains

      GENE
    16. Fenrick, R; Amann, JM; Lutterbach, B; Wang, LL; Westendorf, JJ; Downing, JR; Hiebert, SW
      Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein

      MOLECULAR AND CELLULAR BIOLOGY
    17. Lutterbach, B; Hou, Y; Durst, KL; Hiebert, SW
      The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    18. STROM DK; CLEVELAND JL; CHELLAPPAN S; NIP J; HIEBERT SW
      E2F-1 AND E2F-3 ARE FUNCTIONALLY DISTINCT IN THEIR ABILITY TO PROMOTEMYELOID CELL-CYCLE PROGRESSION AND BLOCK GRANULOCYTE DIFFERENTIATION

      Cell growth & differentiation
    19. JI CH; CASINGHINO S; CHANG DJ; CHEN Y; JAVED A; ITO Y; HIEBERT SW; LIAN JB; STEIN GS; MCCARTHY TL; CENTRELLA M
      CBFA(AML PEBP2)-RELATED ELEMENTS IN THE TGF-BETA TYPE-I RECEPTOR PROMOTER AND EXPRESSION WITH OSTEOBLAST DIFFERENTIATION/

      Journal of cellular biochemistry
    20. Fenrick, R; Hiebert, SW
      Role of histone deacetylases in acute leukemia

      JOURNAL OF CELLULAR BIOCHEMISTRY
    21. PETROVICK HS; HIEBERT SW; FRIEDMAN AD; HETHERINGTON CJ; TENEN DG; ZHANG DE
      MULTIPLE FUNCTIONAL DOMAINS OF AML1 - PU.1 AND C EBP-ALPHA SYNERGIZE WITH DIFFERENT REGIONS OF AML1/

      Molecular and cellular biology
    22. LUTTERBACH B; SUN DX; SCHUETZ J; HIEBERT SW
      THE MYND MOTIF IS REQUIRED FOR REPRESSION OF BASAL TRANSCRIPTION FROMTHE MULTIDRUG-RESISTANCE-1 PROMOTER BY THE T(8-21) FUSION PROTEIN

      Molecular and cellular biology
    23. LUTTERBACH B; WESTENDORF JJ; LINGGI B; PATTEN A; MONIWA M; DAVIE JR; HUYNH KD; BARDWELL VJ; LAVINSKY RM; ROSENFELD MG; GLASS C; SETO E; HIEBERT SW
      ETO, A TARGET OF T(8-21) IN ACUTE-LEUKEMIA, INTERACTS WITH THE N-COR AND MSIN3 COREPRESSORS

      Molecular and cellular biology (Print)
    24. WESTENDORF JJ; YAMAMATO CM; LENNY N; DOWNING JR; SELSTED ME; HIEBERT SW
      THE T(8-21) FUSION PRODUCT, AML-1-ETO, ASSOCIATES WITH C EBP-ALPHA, INHIBITS C/EBP-ALPHA-DEPENDENT TRANSCRIPTION, AND BLOCKS GRANULOCYTIC DIFFERENTIATION/

      Molecular and cellular biology
    25. BANERJEE C; MCCABE LR; CHOI JY; HIEBERT SW; STEIN JL; STEIN GS; LIAN JB
      AML-3 IS A MEMBER OF RHD PROTEINS REQUIRED FOR OSTEOBLAST DIFFERENTIATION

      Journal of bone and mineral research
    26. ZENG CM; VANWIJNEN AJ; LIAN JB; STEIN JL; HIEBERT SW; STEIN GS
      TISSUE-SPECIFIC GENE-REGULATION BY AML CBF-ALPHA/PEBP2/RUNT-HOMOLOGY TRANSCRIPTION FACTORS OCCURS WITHIN DISTINCT SUBNUCLEAR DOMAINS - INTRANUCLEAR TRAFFICKING OF AML VIA A SPECIFIC NUCLEAR MATRIX TARGETING SIGNAL/

      Journal of bone and mineral research
    27. BANERJEE C; MCCABE LR; CHOI JY; HIEBERT SW; STEIN JL; STEIN GS; LIAN JB
      RUNT HOMOLOGY DOMAIN PROTEINS IN OSTEOBLAST DIFFERENTIATION - AML3 CBFA1 IS A MAJOR COMPONENT OF A BONE-SPECIFIC COMPLEX/

      Journal of cellular biochemistry
    28. LENNY N; WESTENDORF JJ; HIEBERT SW
      TRANSCRIPTIONAL REGULATION DURING MYELOPOIESIS

      Molecular biology reports
    29. NIP J; STROM DK; FEE BE; ZAMBETTI G; CLEVELAND JL; HIEBERT SW
      E2F-1 COOPERATES WITH TOPOISOMERASE-II INHIBITION AND DNA-DAMAGE TO SELECTIVELY AUGMENT P53-INDEPENDENT APOPTOSIS

      Molecular and cellular biology
    30. ZENG CM; VANWIJNEN AJ; STEIN JL; MEYERS S; SUN WH; SHOPLAND L; LAWRENCE JB; PENMAN S; LIAN JB; STEIN GS; HIEBERT SW
      IDENTIFICATION OF A NUCLEAR MATRIX TARGETING SIGNAL IN THE LEUKEMIA AND BONE-RELATED AML CBF-ALPHA - TRANSCRIPTION FACTORS/

      Proceedings of the National Academy of Sciences of the United Statesof America
    31. PETROVICK MS; HIEBERT SW; FRIEDMAN AD; HETHERINGTON CJ; TENEN DG; ZHANG DE
      MULTIPLE FUNCTIONAL DOMAINS OF AML1 - PU.1 AND C EBP-ALPHA COOPERATE WITH DIFFERENT REGIONS OF AML1/

      Blood
    32. NIP J; STROM DK; ZAMBETTI G; CLEVELAND JL; HIEBERT SW
      E2F-1-MEDIATED INDUCTION OF P53 IN MYELOID PROGENITOR CELLS SUPPRESSES TOPOISOMERASE II-ALPHA

      Blood
    33. WESTENDORF JJ; YAMAMOTO CM; LENNY N; DOWNING JR; SELSTED ME; HIEBERT SW
      THE T(8-21) FUSION PRODUCT, AML-1 ETO, ASSOCIATES WITH C/EBP-ALPHA, INHIBITS C/EBP-ALPHA-DEPENDENT TRANSCRIPTION AND BLOCKS GRANULOCYTIC DIFFERENTIATION/

      Blood
    34. STROM D; WESTENDORF J; LENNY N; NIP J; LUTTERBACH B; DOWNING J; HIEBERT SW
      OVEREXPRESSION OF AML-1B SHORTENS THE G1 PHASE OF THE CELL-CYCLE

      Blood
    35. MEYERS S; LENNY N; SUN WH; HIEBERT SW
      AML-2 IS A POTENTIAL TARGET FOR TRANSCRIPTIONAL REGULATION BY THE T(8-21) AND T(12-21) FUSION PROTEINS IN ACUTE-LEUKEMIA

      Oncogene
    36. HIEBERT SW; SUN WH; DAVIS JN; GOLUB T; SHURTLEFF S; BUIJS A; DOWNING JR; GROSVELD G; ROUSSEL MF; GILLILAND DG; LENNY N; MEYERS S
      THE T(12-21) TRANSLOCATION CONVERTS AML-1B FROM AN ACTIVATOR TO A REPRESSOR OF TRANSCRIPTION

      Molecular and cellular biology
    37. ZHANG DE; HETHERINGTON CJ; MEYERS S; RHOADES KL; LARSON CJ; CHEN HM; HIEBERT SW; TENEN DG
      CCAAT ENHANCER-BINDING PROTEIN (C EBP) AND AML1 (CBF-ALPHA-2) SYNERGISTICALLY ACTIVATE THE MACROPHAGE-COLONY-STIMULATING FACTOR-RECEPTOR PROMOTER/

      Molecular and cellular biology
    38. OKUDA T; VANDEURSEN J; HIEBERT SW; GROSVELD G; DOWNING JR
      AML1, THE TARGET OF MULTIPLE CHROMOSOMAL TRANSLOCATIONS IN HUMAN LEUKEMIA, IS ESSENTIAL FOR NORMAL FETAL LIVER HEMATOPOIESIS

      Cell
    39. RHOADES KL; HETHERINGTON CJ; ROWLEY JD; HIEBERT SW; NUCIFORA G; TENEN DG; ZHANG DE
      SYNERGISTIC UP-REGULATION OF THE MYELOID-SPECIFIC PROMOTER FOR THE MACROPHAGE-COLONY-STIMULATING FACTOR-RECEPTOR BY AML1 AND THE T(8-21) FUSION PROTEIN MAY CONTRIBUTE TO LEUKEMOGENESIS

      Proceedings of the National Academy of Sciences of the United Statesof America
    40. BANERJEE C; HIEBERT SW; STEIN JL; LIAN JB; STEIN GS
      AN AML-1 CONSENSUS SEQUENCE BINDS AN OSTEOBLAST-SPECIFIC COMPLEX AND TRANSCRIPTIONALLY ACTIVATES THE OSTEOCALCIN GENE

      Proceedings of the National Academy of Sciences of the United Statesof America
    41. HITOMI M; SHU JY; STROM D; HIEBERT SW; HARTER ML; STACEY DW
      PROSTAGLANDIN A(2) BLOCKS THE ACTIVATION OF G(1) PHASE CYCLIN-DEPENDENT KINASE WITHOUT ALTERING MITOGEN-ACTIVATED PROTEIN-KINASE STIMULATION

      The Journal of biological chemistry
    42. STROM DK; CLEVELAND JL; HIEBERT SW
      E2F-1, BUT NOT E2F-3, CAN ACCELERATE APOPTOSIS, BLOCK DIFFERENTIATION, AND REPLACE IL-3 FOR CELL-CYCLE PROGRESSION IN THE PROMYELOCYTIC CELL-LINE 32D.CL3

      Blood
    43. OKUDA T; VANDEURSEN J; HIEBERT SW; GROSVELD G; DOWNING JR
      GENETIC-ANALYSIS OF AML-1 FUNCTION IN NORMAL AND LEUKEMIC HEMATOPOIESIS

      Blood
    44. NIP J; STROM DK; CLEVELAND JL; ZAMBETTI G; HIEBERT SW
      COOPERATION BETWEEN E2F-1 OVEREXPRESSION AND TOPOISOMERASE-II INHIBITION IN THE INDUCTION OF APOPTOSIS IN 32D.3 MYELOID PROGENITOR CELLS

      Blood
    45. TANAKA K; TANAKA T; KUROKAWA M; IMAI Y; OGAWA S; HIEBERT SW; MITANI K; YAZAKI Y; HIRAI H
      THE AML1 ETO(MTG8) AND AML1/EVI-1 LEUKEMIA-ASSOCIATED CHIMERIC ONCOPROTEINS ACCUMULATE PEBP2-BETA(CBF-BETA) IN THE NUCLEUS MORE EFFICIENTLYTHAN WILD-TYPE AML1/

      Blood
    46. LENNY N; MEYERS S; HIEBERT SW
      FUNCTIONAL DOMAINS OF THE T(8-21) FUSION PROTEIN, AML-1 ETO/

      Oncogene
    47. FRANK R; ZHANG J; UCHIDA H; MEYERS S; HIEBERT SW; NIMER SD
      THE AML1 ETO FUSION PROTEIN BLOCKS TRANSACTIVATION OF THE GM-CSF PROMOTER BY AML1B/

      Oncogene
    48. MEYERS S; LENNY N; HIEBERT SW
      THE T(8-21)-FUSION PROTEIN INTERFERES WITH AML-1B-DEPENDENT TRANSCRIPTIONAL ACTIVATION

      Molecular and cellular biology
    49. HIEBERT SW; PACKHAM G; STROM DK; HAFFNER R; OREN M; ZAMBETTI G; CLEVELAND JL
      E2F-1 DP-1 INDUCES P53 AND OVERRIDES SURVIVAL FACTORS TO TRIGGER APOPTOSIS/

      Molecular and cellular biology
    50. GOLUB TR; BARKER GF; BOHLANDER SK; HIEBERT SW; WARD DC; BRAYWARD P; MORGAN E; RAIMONDI SC; ROWLEY JD; GILLILAND DG
      FUSION OF THE TEL GENE ON 12P13 TO THE AML1 GENE ON 21Q22 IN ACUTE LYMPHOBLASTIC-LEUKEMIA

      Proceedings of the National Academy of Sciences of the United Statesof America
    51. MEYERS S; LENNY N; SUN WH; HIEBERT SW
      AML-2 IS A POTENTIAL TARGET FOR THE T(8-21) FUSION PROTEIN IN MYELOIDCELLS

      Blood
    52. ZHANG DE; HETHERINGTON CJ; MEYERS S; LERHOADES K; CHEN HM; HIEBERT SW; TENEN DG
      CCAAT ENHANCER-BINDING PROTEIN (C EBP) AND AML1 (CBFA2) SYNERGISTICALLY ACTIVATE THE M-CSF RECEPTOR PROMOTER/

      Blood
    53. OKUDA T; VANDEURSEN J; HIEBERT SW; GROSVELD G; DOWNING JR
      AML-1, THE TARGET OF MULTIPLE CHROMOSOMAL TRANSLOCATIONS IN HUMAN LEUKEMIA, IS ESSENTIAL FOR NORMAL MURINE FETAL LIVER HEMATOPOIESIS

      Blood
    54. SHURTLEFF SA; MEYERS S; HIEBERT SW; RAIMONDI SC; HEAD DR; WILLMAN CL; WOLMAN S; SLOVAK ML; CARROLL AJ; BEHM F; HULSHOF MG; MOTRONI TA; OKUDA T; LIU P; COLLINS FS; DOWNING JR
      HETEROGENEITY IN CBF-BETA MYH11 FUSION MESSAGES ENCODED BY THE INV(16)(P13Q22) AND THE T(16-16)(P13-Q22) IN ACUTE MYELOGENOUS LEUKEMIA/

      Blood
    55. DOBROWOLSKI SF; STACEY DW; HARTER ML; STINE JT; HIEBERT SW
      AN E2F DOMINANT-NEGATIVE MUTANT BLOCKS E1A INDUCED CELL-CYCLE PROGRESSION

      Oncogene
    56. ROUSSEL MF; DAVIS JN; CLEVELAND JL; GHYSDAEL J; HIEBERT SW
      DUAL CONTROL OF MYC EXPRESSION THROUGH A SINGLE DNA-BINDING SITE TARGETED BY ETS FAMILY PROTEINS AND E2F-1

      Oncogene
    57. SAITO M; HIEBERT SW; INUKAI T; ASHMUN RA; LOOK AT
      EFFECTS OF E2F-1 ON THE EMBRYONIC DEVELOPMENTAL PROGRAM OF K562-ERYTHROLEUKEMIA CELLS

      Blood
    58. MEYERS S; LENNY N; HIEBERT SW
      CLONING OF THE TRANSCRIPTIONALLY ACTIVE FORM OF AML-1, AML-1B - THE T(8-21) FUSION PROTEIN (AML-1 ETO) IS INACTIVE FOR AML-1B-DEPENDENT TRANSACTIVATION

      Blood
    59. HIEBERT SW
      REGIONS OF THE RETINOBLASTOMA GENE-PRODUCT REQUIRED FOR ITS INTERACTION WITH THE E2F TRANSCRIPTION FACTOR ARE NECESSARY OF E2 PROMOTER REPRESSION AND PRB-MEDIATED GROWTH SUPPRESSION

      Molecular and cellular biology
    60. MEYERS S; DOWNING JR; HIEBERT SW
      IDENTIFICATION OF AML-1 AND THE (8 21) TRANSLOCATION PROTEIN (AML-1 ETO) AS SEQUENCE-SPECIFIC DNA-BINDING PROTEINS - THE RUNT HOMOLOGY DOMAIN IS REQUIRED FOR DNA-BINDING AND PROTEIN-PROTEIN INTERACTIONS/

      Molecular and cellular biology
    61. FRIEDMAN AD; MEYERS S; HIEBERT SW; SUZOW J
      PEBP2-ALPHA-B, THE MURINE HOMOLOG OF AML1, BINDS AND TRANSCRIPTIONALLY ACTIVATES THE MYELOPEROXIDASE PROMOTER

      Blood
    62. MEYERS S; DOWNING JR; HIEBERT SW
      IDENTIFICATION OF AML-1 AND THE (8, 21) TRANSLOCATION PROTEIN (AML-1 ETO) AS SEQUENCE-SPECIFIC DNA-BINDING PROTEINS - THE RUNT HOMOLOGY DOMAIN IS REQUIRED FOR DNA-BINDING AND INTERACTIONS WITH THE INV(16) FUSION PROTEIN/

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 16:41:29